D-1543-2020 Class II Terminated
FDA drug recall D-1543-2020 was initiated by BAYSHORE PHARMACEUTICALS on Aug 19, 2020 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Apr 26, 2021). Affected quantity: 594 bottles.
Recall details
- Product Type
- Drugs
- Report Date
- Sep 2, 2020
- Initiation Date
- Aug 19, 2020
- Termination Date
- Apr 26, 2021
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 594 bottles
Product description
Metformin Hydrochloride Extended-Release Tablets USP, 500 mg 1000 Tablets Rx Only Manufactured by: Beximco Pharmaceuticals, LTD. 126, Kathaldia, Tongi, Gazipur, 1711, Bangladesh NDC 76385-128-10
Reason for recall
CGMP Deviations
Distribution pattern
nationwide
Code information
Lot #18641; Exp. 05/2021
Source
- Dataset
- openFDA drug recall enforcement reports
- FDA record
- This recall in openFDA (JSON)
- Enforcement Report
- Search FDA's Enforcement Report for D-1543-2020
- openFDA file date
- Nov 16, 2026
- Loaded by RegDataLab
- Nov 17, 2026